4.6 Article

Erythropoietin is reduced by combination of diuretic therapy and RAAS blockade in proteinuric renal patients with preserved renal function

Related references

Note: Only part of the references are listed.
Review Urology & Nephrology

Erythropoietin and renoprotection

Ferdinand H. Bahlmann et al.

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2009)

Article Urology & Nephrology

Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan

Liffert Vogt et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)

Article Urology & Nephrology

Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents

VLM Esnault et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)

Article Medicine, General & Internal

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

BM Brenner et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)